Key result
An inactivated field isolate EMCV vaccine produced fourfold increases in titers in 62% of rhesus macaques, whereas an inactivated porcine field strain vaccine produced no titers.
Why the study?
Does an inactivated zoo isolate EMCV vaccine produce better antibody responses than a porcine field strain vaccine in rhesus macaques?
Does an inactivated zoo isolate EMCV vaccine produce better antibody responses than a porcine field strain vaccine in rhesus macaques?
An inactivated EMCV vaccine derived from a zoo isolate successfully induced persistent antibody responses in rhesus macaques, unlike a porcine strain vaccine.
Answers are grounded in this paper and cite their sources.
Zoo isolate EMCV vaccines merit primate testing; leaves open strain optimization and field translation.
Two groups of rhesus macaques (Macaca mulatta) housed in rodent-controlled outdoor corrals were inoculated with two different encephalomyocarditis virus (EMCV) vaccines. One group (n = 45) received a vaccine made from an inactivated field isolate of virus cultured during an outbreak at a zoo in Florida. This vaccine produced fourfold increases in the titers of 28 animals (62%); the increases persisted for at least 18 months (last test) after a single injection of the vaccine. The other group (n = 51) received a vaccine made from an inactivated porcine field strain of the virus. This vaccine did not produce titers in any of the vaccinees.
No takes yet. Share an insight, caveat, or question.
Emerson et al. (1996) studied Encephalomyocarditis virus (EMCV) vaccination (n=96). Inactivated field isolate of EMCV vaccine (Florida zoo outbreak) vs. Inactivated porcine field strain of EMCV vaccine was evaluated on Fourfold increases in antibody titers. An inactivated field isolate EMCV vaccine produced fourfold increases in titers in 62% of rhesus macaques, whereas an inactivated porcine field strain vaccine produced no titers.
Synapse has enriched 10 related papers. Consider them for comparative context: